Company
Team
CORPORATE GOVERNANCE
Platforms
Glycovirology
Degenerative Diseases
pipeline
ProLectin Pipeline
Degenerative Disease pipeline
Resources
IN THE NEWS
Stroke video
faq
SCIENTIFIC PUBLICATIONS
investors
Company presentation
press releases
Reports
financial
Contact US
$BIXT
Company
Platforms
Glycovirology
Degenerative Diseases
Resources
Investors
Pipeline
contact us
Glycovirology Scientific Publications
featured
Galectin approach to lower covid transmission - Drug Development for clinical use
Galectin approach to lower covid transmission - Drug Development for clinical use
The Two Nobel Prize Investment
The Two Nobel Prize Investment
Galectin Antagonist use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial
Galectin Antagonist use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial
Previous
load more
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
Receptor Recognition Mechanisms of Coronaviruses: a Decade of Structural Studies
The role of galectins in virus infection - A systemic literature review
The role of galectins in virus infection - A systemic literature review
Roles of galectins in infection
Roles of galectins in infection
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
A potential role for Galectin-3 inhibitors in the treatment of COVID-19
Previous
load more
go back